Neoadjuvant Therapy Prior to Prostatectomy: Is the Glass Half Full?

Affiliations

¹ University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA. Electronic address: rbmontgo@uw.edu.
² University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.

Editorial

Bruce Montgomery et al. Eur Urol. 2023 Jun.

. 2023 Jun;83(6):519-520.

doi: 10.1016/j.eururo.2023.01.021. Epub 2023 Jan 27.

¹ University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA. Electronic address: rbmontgo@uw.edu.
² University of Washington School of Medicine, Seattle, WA, USA; VA Puget Sound Health Care System, Seattle, WA, USA; Fred Hutchinson Cancer Center, Seattle, WA, USA.

No abstract available

Comment on

ARNEO: A Randomized Phase II Trial of Neoadjuvant Degarelix with or Without Apalutamide Prior to Radical Prostatectomy for High-risk Prostate Cancer.
Devos G, Tosco L, Baldewijns M, Gevaert T, Goffin K, Petit V, Mai C, Laenen A, Raskin Y, Van Haute C, Goeman L, De Meerleer G, Berghen C, Devlies W, Claessens F, Van Poppel H, Everaerts W, Joniau S. Devos G, et al. Eur Urol. 2023 Jun;83(6):508-518. doi: 10.1016/j.eururo.2022.09.009. Epub 2022 Sep 24. Eur Urol. 2023. PMID: 36167599 Clinical Trial.